The resistance of different types of fungi against ordinary antifungal drugs has been widely reported. The continuous search for a new compound with effective antifungal properties is therefore important and continuous. The present descriptive study aims to estimate the effectiveness of a new compound (HCX), prepared from the reaction of hydrocortisone with cefotaxime, as an in vitro antifungal drug. Five pathogenic fungi samples (Mentagrophytes canis, Mentagrophytes gypseum, Trichophyton mentagrophyte, Trichophyton rubrum, and Trichophyton verrucosum) were collected in this study. The antifungal activity of the HCX was determined via agar dilution method using three different concentrations of HCX
(1, 2, and 3 µg/mL, respectively). The inhibition efficacy of each HCX concentration on the fungus growth was expressed as the mean inhibition percentage and the mean inhibition concentration.
The results indicate the effective inhibition of growth of the fungi, especially at higher concentrations of the HCX compound.
At 3 µg/mL of HCX concentration, 100% inhibition occurred, except in the case of M. canis, which was at 77.8% at the relatively lower concentration of 1%. The new compound, formed from the reaction between cefotaxime and hydrocortisone (HCX), has the ability to inhibit the growth of five types of dermatophytes in low doses, comparable to well-known antifungal drugs.
PDF (817.90 KB PDF FORMAT)
RIS citation (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)
BibTex citation (BIBDESK, LATEX)
I highly recommend publication in Libertas Academia journals. The entire submission, review and publication process for our article in Clinical Medicine Insights: Dermatology was easy and quick. The reviews were very professional and helpful and the publication fees were reasonable. We also appreciate that our article is available online free of charge to anyone interested in it.
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.See Our Results
Copyright © 2013 Libertas Academica Ltd (except open access articles and accompanying metadata and supplementary files.)